Skip to main content
Figure 2 | Theoretical Biology and Medical Modelling

Figure 2

From: Transient antiretroviral therapy selecting for common HIV-1 mutations substantially accelerates the appearance of rare mutations

Figure 2

Surface plots of waiting times as a function of drug efficacy. Surface plot showing the waiting times to the occurrence of rare mutations as a function of drug efficacy on viral strains (ξ i ) for (a) k2 = 0.9k1 and (b) k2 = 0.1k1 where k1 = 2 × 10-8. The point ((ξ1, ξ2) = (0, 0)) represents potent treatment that results in viral elimination. Less effective selection pressure or treatment that successfully suppresses both viral subpopulations results in increased waiting times or even guarantees the non-occurrence of rare mutations. Suboptimal treatment that suppresses the wild-type strain but barely affects the common mutant leads to dramatic reduction in waiting times to the occurrence of rare mutations. On the other hand, treatment that affects the common mutant but allows continuation of wild-type strain replication, increases the waiting time to the occurrence of a rare mutant.

Back to article page